18,868 Cencora, Inc. $COR Shares Sold by Vista Investment Partners LLC

Vista Investment Partners LLC reduced its position in Cencora, Inc. (NYSE:COR) by 96.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 686 shares of the company’s stock after selling 18,868 shares during the quarter. Vista Investment Partners LLC’s holdings in Cencora were worth $206,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of COR. Elevation Wealth Partners LLC lifted its holdings in shares of Cencora by 506.2% in the 2nd quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Bell Investment Advisors Inc purchased a new position in Cencora in the 2nd quarter worth $28,000. Caitlin John LLC purchased a new position in Cencora in the 2nd quarter worth $28,000. Cassaday & Co Wealth Management LLC bought a new stake in Cencora in the first quarter worth $35,000. Finally, Western Wealth Management LLC bought a new stake in Cencora in the first quarter worth $49,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Wells Fargo & Company raised their price objective on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Robert W. Baird set a $370.00 target price on Cencora in a report on Thursday, August 6th. Weiss Ratings upgraded Cencora from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday. Leerink Partners boosted their price objective on Cencora from $380.00 to $388.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. increased their price objective on Cencora from $382.00 to $390.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $372.07.

Insiders Place Their Bets

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the transaction, the executive vice president owned 19,455 shares in the company, valued at approximately $6,305,754.60. This represents a 36.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Trading Up 1.0%

COR stock traded up $3.22 on Thursday, reaching $320.47. The company’s stock had a trading volume of 294,091 shares, compared to its average volume of 1,479,906. The firm has a market cap of $61.16 billion, a PE ratio of 23.81, a PEG ratio of 1.62 and a beta of 0.58. The business has a fifty day simple moving average of $318.08 and a two-hundred day simple moving average of $302.75. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, topping the consensus estimate of $4.35 by $0.13. The business had revenue of $84.75 billion during the quarter, compared to analyst estimates of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the business earned $4.00 EPS. As a group, research analysts forecast that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s payout ratio is presently 17.83%.

Cencora Company Profile

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical solutions company that sources, distributes and supports the delivery of medicines and healthcare products. The company serves pharmaceutical manufacturers, healthcare providers, pharmacies and animal-health customers through its supply-chain and commercialization services.

Its activities include pharmaceutical and specialty-product distribution, manufacturer services, specialty logistics, clinical-trial support, patient-support programs and other services designed to help bring medicines to market and improve access to treatment.